Inotek Pharmaceuticals Corporation Announces Publication of Phase 1 Data for Trabodenoson in Healthy Adult Volunteers in the Journal of Ocular Pharmacology and Therapeutics

by Business Wire • 2016/04/21 • 0 Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals announces the publication of Phase 1 data for trabodenoson in healthy adult volunteers in the Journal of Ocular Pharmacology and Therapeutics (JOPT).

← A better understanding of bananas could help prevent blindness

VIDEO: Boston keratoprosthesis in severe external disease →

Post navigation